Psychiatric and legal considerations for ketamine treatment within prison settings.
Michael Bayrhammer-Savel, Martin Ortner, Marie Claire Van Hout, Arkadiusz Komorowski
Frontiers in Psychiatry 2024 DOI: 10.3389/fpsyt.2024.1316108 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Perspective or opinion paper Peer reviewed |
|---|---|
| Intervention | Ketamine treatment |
| Topics | Depression Ketamine Esketamine |
| Keywords | Human rights Suicidality Treatment resistant depression Prison mental health Ketamine therapy Correctional psychiatry |
| Citations | 6 |
| Key points | Argues that access to ketamine treatment in prisons is both a psychiatric necessity and a human rights obligation, while acknowledging the need for further research on risks and benefits. |
Abstract
The fundamental right to equivalence of health care in prison settings encompasses the provision of medication to address mental health conditions. Considering the increased risk for self-harm among individuals dealing with depression, the limited effectiveness of conservative antidepressants is a major challenge in psychiatry. The high prevalence of suicidal tendencies within prison populations underscores the imperative for state-of-the-art pharmacological treatment to uphold adequate health care standards. Notably, the denial of access to effective medication could be deemed a violation of human rights of people living in prison according to international treaties, domestic law, and United Nations normative standards of detention. This article presents the authors' perspective on the accessibility of ketamine treatment in prison settings, discussing psychiatric and legal considerations as well as current challenges in this context. Implementing novel psychopharmacological interventions may alleviate the distress experienced by individuals struggling with depressive symptoms and suicidality. At the same time, unprecedented treatment alternatives bring along potential issues, including limited understanding of long-term effects and the risk of abuse. Given the scarce data-availability, a pressing need exists for further research on the benefits and risks of ketamine treatment within prison populations.